199 related articles for article (PubMed ID: 8784215)
1. Felbamate.
Leppik IE
Epilepsia; 1995; 36 Suppl 2():S66-72. PubMed ID: 8784215
[TBL] [Abstract][Full Text] [Related]
2. Felbamate.
Pellock JM
Epilepsia; 1999; 40 Suppl 5():S57-62. PubMed ID: 10530695
[TBL] [Abstract][Full Text] [Related]
3. Felbamate: successful development of a new compound for the treatment of epilepsy.
Schmidt D
Epilepsia; 1993; 34 Suppl 7():S30-3. PubMed ID: 8243376
[TBL] [Abstract][Full Text] [Related]
4. Discontinuation of phenytoin and carbamazepine in patients receiving felbamate.
Wagner ML; Graves NM; Marienau K; Holmes GB; Remmel RP; Leppik IE
Epilepsia; 1991; 32(3):398-406. PubMed ID: 1904346
[TBL] [Abstract][Full Text] [Related]
5. Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate.
Sachdeo R; Wagner ML; Sachdeo S; Shumaker RC; Lyness WH; Rosenberg A; Ward D; Perhach JL
Epilepsia; 1999 Aug; 40(8):1122-8. PubMed ID: 10448826
[TBL] [Abstract][Full Text] [Related]
6. Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsy.
Sachdeo R; Narang-Sachdeo SK; Shumaker RC; Perhach JL; Lyness WH; Rosenberg A
Epilepsia; 1997 Aug; 38(8):887-92. PubMed ID: 9579889
[TBL] [Abstract][Full Text] [Related]
7. Felbamate levels in patients with epilepsy.
Harden CL; Trifiletti R; Kutt H
Epilepsia; 1996 Mar; 37(3):280-3. PubMed ID: 8598188
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of case reports of aplastic anemia among patients treated with felbamate.
Kaufman DW; Kelly JP; Anderson T; Harmon DC; Shapiro S
Epilepsia; 1997 Dec; 38(12):1265-9. PubMed ID: 9578520
[TBL] [Abstract][Full Text] [Related]
9. Antiepileptic drugs in development: prospects for the near future.
Leppik IE
Epilepsia; 1994; 35 Suppl 4():S29-40. PubMed ID: 8174517
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic drug monitoring of felbamate].
Tribut O; Bentué-Ferrer D; Verdier MC;
Therapie; 2010; 65(1):35-8. PubMed ID: 20205993
[TBL] [Abstract][Full Text] [Related]
11. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy.
Palmer KJ; McTavish D
Drugs; 1993 Jun; 45(6):1041-1065. PubMed ID: 7691493
[TBL] [Abstract][Full Text] [Related]
12. Felbamate.
Bourgeois BF
Semin Pediatr Neurol; 1997 Mar; 4(1):3-8. PubMed ID: 9097361
[TBL] [Abstract][Full Text] [Related]
13. Felbamate: clinical and molecular aspects of a unique antiepileptic drug.
Brown WM; Aiken SP
Crit Rev Neurobiol; 1998; 12(3):205-22. PubMed ID: 9847055
[TBL] [Abstract][Full Text] [Related]
14. Felbamate-induced headache.
Ettinger AB; Jandorf L; Berdia A; Andriola MR; Krupp LB; Weisbrot DM
Epilepsia; 1996 May; 37(5):503-5. PubMed ID: 8617182
[TBL] [Abstract][Full Text] [Related]
15. Felbamate in refractory partial epilepsy.
Canger R; Vignoli A; Bonardi R; Guidolin L
Epilepsy Res; 1999 Mar; 34(1):43-8. PubMed ID: 10194111
[TBL] [Abstract][Full Text] [Related]
16. Felbamate in an adult population with severe refractory epilepsy.
Kearney H; Delanty N
Ir Med J; 2009; 102(10):326-8. PubMed ID: 20108801
[TBL] [Abstract][Full Text] [Related]
17. Felbamate monotherapy has stimulant-like effects in patients with epilepsy.
Ketter TA; Malow BA; Flamini R; Ko D; White SR; Post RM; Theodore WH
Epilepsy Res; 1996 Mar; 23(2):129-37. PubMed ID: 8964274
[TBL] [Abstract][Full Text] [Related]
18. [Felbamate: a long-term study in subjects with refractory epilepsy].
De Romanis F; Sopranzi N
Clin Ter; 1997 Mar; 148(3):83-7. PubMed ID: 9377844
[TBL] [Abstract][Full Text] [Related]
19. Felbamate in the treatment of partial-onset seizures.
Bourgeois BF
Epilepsia; 1994; 35 Suppl 5():S58-61. PubMed ID: 8039474
[TBL] [Abstract][Full Text] [Related]
20. [The pharmacologic and clinical profile of the new anticonvulsant felbamate--an overview].
Steinhoff BJ
Fortschr Neurol Psychiatr; 1994 Oct; 62(10):379-88. PubMed ID: 8001894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
